3 Stocks Underperforming Today In The Energy Industry

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 14 points (0.1%) at 16,515 as of Thursday, April 24, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,645 issues advancing vs. 1,332 declining with 182 unchanged.

The Energy industry currently sits up 0.3% versus the S&P 500, which is up 0.3%. On the negative front, top decliners within the industry include Williams Companies ( WMB), down 1.4%, Williams Partners ( WPZ), down 1.1%, Halliburton ( HAL), down 0.8% and China Petroleum & Chemical ( SNP), down 0.8%. Top gainers within the industry include Diamond Offshore Drilling ( DO), up 7.6%, Cabot Oil & Gas ( COG), up 4.5%, Devon Energy ( DVN), up 1.1%, Total ( TOT), up 1.0% and TransCanada ( TRP), up 1.0%.

TheStreet would like to highlight 3 stocks pushing the industry lower today:

3. Core Laboratories ( CLB) is one of the companies pushing the Energy industry lower today. As of noon trading, Core Laboratories is down $20.66 (-9.7%) to $193.03 on heavy volume. Thus far, 826,695 shares of Core Laboratories exchanged hands as compared to its average daily volume of 304,500 shares. The stock has ranged in price between $192.20-$201.89 after having opened the day at $199.99 as compared to the previous trading day's close of $213.69.

Core Laboratories N.V. provides reservoir description, production enhancement, and reservoir management services to the oil and gas industry in the Netherlands and internationally. The company operates in three segments: Reservoir Description, Production Enhancement, and Reservoir Management. Core Laboratories has a market cap of $9.6 billion and is part of the basic materials sector. Shares are up 11.9% year-to-date as of the close of trading on Wednesday. Currently there are 3 analysts that rate Core Laboratories a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Core Laboratories as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, expanding profit margins, impressive record of earnings per share growth and solid stock price performance. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full Core Laboratories Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Enterprise Products Partners ( EPD) is down $0.37 (-0.5%) to $72.78 on average volume. Thus far, 429,586 shares of Enterprise Products Partners exchanged hands as compared to its average daily volume of 1.1 million shares. The stock has ranged in price between $72.72-$73.86 after having opened the day at $73.61 as compared to the previous trading day's close of $73.15.

Enterprise Products Partners L.P. provides midstream energy services to producers and consumers of natural gas, natural gas liquids (NGLs), crude oil, petrochemicals, and refined products in the United States and internationally. Enterprise Products Partners has a market cap of $69.2 billion and is part of the basic materials sector. Shares are up 10.3% year-to-date as of the close of trading on Wednesday. Currently there are 14 analysts that rate Enterprise Products Partners a buy, no analysts rate it a sell, and 2 rate it a hold.

TheStreet Ratings rates Enterprise Products Partners as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, growth in earnings per share, increase in net income and solid stock price performance. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Enterprise Products Partners Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, Helmerich & Payne ( HP) is down $5.06 (-4.5%) to $108.75 on heavy volume. Thus far, 1.5 million shares of Helmerich & Payne exchanged hands as compared to its average daily volume of 1.2 million shares. The stock has ranged in price between $108.17-$117.00 after having opened the day at $114.41 as compared to the previous trading day's close of $113.81.

Helmerich & Payne, Inc. primarily operates as a contract drilling company in North and South America. Helmerich & Payne has a market cap of $12.2 billion and is part of the basic materials sector. Shares are up 35.4% year-to-date as of the close of trading on Wednesday. Currently there are 3 analysts that rate Helmerich & Payne a buy, 2 analysts rate it a sell, and 10 rate it a hold.

TheStreet Ratings rates Helmerich & Payne as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Helmerich & Payne Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the energy industry could consider Energy Select Sector SPDR ( XLE) while those bearish on the energy industry could consider Proshares Short Oil & Gas ( DDG).

null

More from Markets

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists

Purdue Pharma Unloads Sales Staff, Transitioning From Painkiller Focus

Purdue Pharma Unloads Sales Staff, Transitioning From Painkiller Focus

Dow Finishes Lower as Nasdaq Posts New Record

Dow Finishes Lower as Nasdaq Posts New Record

Airlines Rebuke Trump Policy of Separating Children

Airlines Rebuke Trump Policy of Separating Children

Deutsche Bank Fined $205 Million Over Currency-Trading Violations

Deutsche Bank Fined $205 Million Over Currency-Trading Violations